Inderal Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
Conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IV Esophageal Adenocarcinoma AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcin oma AJCC v8; Locally Advanced Esophageal Adenocarcinoma; Locally Advanced Gastroesophageal Junction Adenocarcinoma; Metastatic Esophageal Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Unresectable Esophageal Adenocarcinoma; Unresectable Gastroesophagea l Junction Adenoc...
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials

Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding
Conditions: Portal Hypertension; Varice Bleed; Cirrhosis, Liver Interventions: Drug: Carvedilol; Drug: Propranolol Sponsors: West China Hospital; Chengdu Shangjin Nanfu Hospital; West China Tianfu Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials

Beta-Adrenergic Modulation of Drug Cue Reactivity
Conditions: Tobacco Use Disorder; Nicotine Dependence; Cigarette Smoking Interventions: Drug: Propranolol; Drug: Nicotine Patch; Drug: Placebo Propranolol; Drug: Placebo Patch Sponsors: University of Oklahoma; Oklahoma State University Center for Health Sciences; Duke University; National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2022 Category: Research Source Type: clinical trials